Past 90 days
Past 90 days
Past 90 days
Past 90 days
Search
Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
---|---|---|---|---|---|---|---|---|
2025-03-19 | 2025-03-17 | S Sale |
Chief Financial Officer Officer |
2,592
-0.6%
4.95USD 12,817 |
2,592 -0.6% | 4.95 | USD 12,817 | |
2025-03-19 | 2025-03-17 | S Sale |
President and CEO Executive Director |
5,092
-0.5%
4.95USD 25,180 |
5,092 -0.5% | 4.95 | USD 25,180 | |
2025-03-19 | 2025-03-17 | S Sale |
Chief Operating Officer Officer |
2,298
-0.9%
4.95USD 11,364 |
2,298 -0.9% | 4.95 | USD 11,364 | |
2025-03-13 | 2025-03-11 | S Sale |
Kynam Global Healthcare Master Fund, LP Large shareholder |
5,142,111
-100.0%
4.93USD 25,350,607 |
5,142,111 -100.0% | 4.93 | USD 25,350,607 | |
2025-03-13 | 2025-03-11 | S Sale |
Kynam Global Healthcare Master Fund, LP Large shareholder |
5,142,111
-100.0%
4.93USD 25,350,607 |
5,142,111 -100.0% | 4.93 | USD 25,350,607 | |
2025-03-13 | 2025-03-11 | S Sale |
Kynam Global Healthcare Master Fund, LP Large shareholder |
5,953,825
-100.0%
4.93USD 29,352,357 |
5,953,825 -100.0% | 4.93 | USD 29,352,357 | |
2025-01-07 | 2025-01-07 | PS Planned sale |
See Remarks Officer |
186
-0.1%
2.64USD 491 |
186 -0.1% | 2.64 | USD 491 | |
2025-01-07 | 2025-01-06 | S Sale | Non-Executive Director |
892
-0.1%
2.78USD 2,478 |
892 -0.1% | 2.78 | USD 2,478 | |
2025-01-07 | 2025-01-06 | PS Planned sale |
See Remarks Officer |
5,000
-3.3%
2.79USD 13,972 |
5,000 -3.3% | 2.79 | USD 13,972 | |
2025-01-07 | 2025-01-06 | S Sale |
See Remarks Officer |
114
-0.1%
2.78USD 317 |
114 -0.1% | 2.78 | USD 317 | |
2025-01-07 | 2025-01-06 | S Sale |
President and CEO Executive Director |
763
-0.1%
2.78USD 2,120 |
763 -0.1% | 2.78 | USD 2,120 | |
2025-01-07 | 2025-01-06 | S Sale |
Chief Financial Officer Officer |
97
-0.0%
2.78USD 270 |
97 -0.0% | 2.78 | USD 270 | |
2025-01-07 | 2025-01-03 | S Sale | Non-Executive Director |
85,978
-6.5%
2.94USD 252,423 |
85,978 -6.5% | 2.94 | USD 252,423 | |
2025-01-07 | 2025-01-03 | S Sale |
See Remarks Officer |
1,000
-0.7%
2.94USD 2,936 |
1,000 -0.7% | 2.94 | USD 2,936 | |
2025-01-07 | 2025-01-03 | S Sale |
President and CEO Executive Director |
31,718
-3.5%
2.94USD 93,121 |
31,718 -3.5% | 2.94 | USD 93,121 | |
2025-01-07 | 2025-01-03 | S Sale |
Chief Financial Officer Officer |
1,013
-0.3%
2.94USD 2,974 |
1,013 -0.3% | 2.94 | USD 2,974 | |
2024-12-17 | 2024-12-13 | PS Planned sale |
See Remarks Officer |
2,287
-1.5%
3.23USD 7,393 |
2,287 -1.5% | 3.23 | USD 7,393 | |
2024-11-20 | 2024-11-18 | S Sale | Non-Executive Director |
3,900
-14.1%
3.38USD 13,182 |
3,900 -14.1% | 3.38 | USD 13,182 | |
2024-10-07 | 2024-10-03 | PS Planned sale |
See Remarks Officer |
679
-0.4%
4.65USD 3,157 |
679 -0.4% | 4.65 | USD 3,157 | |
2024-10-07 | 2024-10-03 | S Sale |
Chief Financial Officer Officer |
1,230
-0.4%
4.65USD 5,718 |
1,230 -0.4% | 4.65 | USD 5,718 |
// ... existing code ...